# AZD0914 Phase 1 ADME Study in Healthy Volunteers

> **NCT02298920** · PHASE1 · COMPLETED · sponsor: **Entasis Therapeutics** · enrollment: 6 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD0914

## Key facts

- **NCT ID:** NCT02298920
- **Lead sponsor:** Entasis Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2015-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02298920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02298920, "AZD0914 Phase 1 ADME Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02298920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*